Italy, Germany, the Netherlands and France have reportedly agreed to pay an initial 750 million euros ($843.2 million) for 300 million doses of AstraZeneca's potential vaccine against Covid-19.
Italy, Germany, the Netherlands and France have agreed to pay an initial 750 million euros for 300 million doses of AstraZeneca's potential vaccine against Covid-19.The vaccine is being developed by Oxford University.Anadolu Agency
The countries will have the option to buy a further 100 million doses of the vaccine, according to the news agency. Italy itself will pay 185 million euros for 75 million doses of the vaccine, which is being developed by Oxford University. The news comes two days after AstraZeneca announced on Saturday it had agreed with the four countries to supply up to 400 million doses of the vaccine, with deliveries set to start by the end of 2020. The pharmaceutical giant said it was building a number of supply chains in parallel across the world and is seeking to expand manufacturing capacity further.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus: Allemagne, France, Italie et Pays-Bas commandent 400 millions de vaccins à AstrazenecaL'Allemagne, la France, l'Italie et les Pays-Bas ont signé avec Astrazeneca un contrat portant sur la fourniture de 400 millions de doses de vaccins contre le coronavirus, a annoncé samedi le ministre italien de la Santé.
Read more »
Coronavirus: AstraZeneca fournira à l'Europe 400 millions de doses de son futur vaccinL'Allemagne, la France, l'Italie et les Pays-Bas ont signé avec Astrazeneca un contrat portant sur la fourniture de 400 millions de doses de son vaccin en développement contre le coronavirus, ont annoncé samedi les pays signataires.
Read more »
AstraZeneca agrees to make COVID-19 vaccine for EuropePharma giant AstraZeneca has struck a deal to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries.
Read more »
AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccineAstraZeneca Plc said on Saturday it signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help combat the pandemic.
Read more »
Four EU countries sign deal with pharma giant for Covid-19 vaccineAstraZeneca, an Anglo-Swedish company, recently completed similar agreements with Britain, the United States the Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance for 700 million doses.
Read more »